
Chinese Researchers Find Immune Cell Fueling Chronic Sinusitis
Researchers from China’s Tsinghua University have discovered that a specific immune cell contributes to chronic sinusitis and nasal polyps, offering new hope for effective treatments.
News & Insights Across Asia
Researchers from China’s Tsinghua University have discovered that a specific immune cell contributes to chronic sinusitis and nasal polyps, offering new hope for effective treatments.
Chinese scientists have discovered that a specific immune cell exacerbates chronic sinus infections, potentially leading to new treatments.
Chinese scientists have uncovered how a specific immune cell worsens chronic sinus infections, potentially leading to new treatments.
A new study from China’s Tsinghua University and Beijing Tongren Hospital reveals that Granzyme K, a protein secreted by specialized immune cells, fuels chronic sinus infections.
Researchers from China’s Tsinghua University and Beijing Tongren Hospital have identified a type of immune cell that exacerbates chronic sinusitis and nasal polyps, opening new avenues for treatment.
Chinese researchers have discovered that a specific immune cell secreting Granzyme K intensifies inflammation in chronic sinusitis and nasal polyps, offering new hope for treatments.
A new study from China’s Tsinghua University and Beijing Tongren Hospital reveals that a specific type of immune cell may worsen chronic sinusitis by fueling persistent inflammation and tissue damage.
Researchers from China\u0027s Tsinghua University have identified Granzyme K, a protein secreted by immune cells, as a key factor worsening chronic sinusitis and nasal polyps.
Researchers from China’s Tsinghua University and Beijing Tongren Hospital have identified Granzyme K as a key factor in chronic sinus infections and nasal polyps.
Researchers from China’s Tsinghua University have identified Granzyme K, secreted by certain immune cells, as a key factor in chronic sinusitis, paving the way for new treatments.
Chinese scientists have discovered that a specific type of immune cell intensifies inflammation in chronic sinus infections, opening new avenues for treatment.
Chinese researchers have discovered that a specific immune cell, once considered a defender, actually worsens chronic sinusitis by fueling inflammation, opening new paths for treatment.
Chinese researchers have identified Granzyme K, a protein secreted by specific immune cells, as a key factor fueling chronic sinus infections and nasal polyps, opening new avenues for treatment.
A groundbreaking study by Chinese scientists has identified Granzyme K, an immune protein, as a key factor worsening chronic sinusitis, offering new hope for effective treatments.
Scientists from Tsinghua University and Beijing Tongren Hospital have discovered that a specific immune cell intensifies inflammation in chronic sinusitis and nasal polyps, offering a new target for treatment.
Scientists from China’s Tsinghua University and Beijing Tongren Hospital have discovered that a specific immune cell can fuel persistent inflammation in chronic sinusitis and nasal polyps.
Researchers from Tsinghua University and Beijing Tongren Hospital have discovered that Granzyme K secreted by certain immune cells exacerbates chronic sinusitis and nasal polyps, offering a new target for treatment.
Researchers from China’s Tsinghua University and Beijing Tongren Hospital discover that a specific immune cell exacerbates chronic sinusitis, offering new hope for treatment.
A new study by researchers from China’s Tsinghua University and Beijing Tongren Hospital has identified Granzyme K, an immune protein, as a key player in worsening chronic sinusitis and nasal polyps.
Chinese scientists have discovered that a specific immune cell worsens chronic sinus infections by fueling inflammation, offering new hope for treatments targeting Granzyme K.